alexa Ramiya Ravindranath | GlaxoSmithKline
ISSN: 0975-0851

Journal of Bioequivalence & Bioavailability
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Ramiya Ravindranath

GlaxoSmithKline, India
Ramiya Ravindranath is a senior R&D Scientist at the GlaxoSmithKline, India. Ramiya Ravindranath's research includes bioavailability studies, clinical research outcomes of inhalation products and parenteral dosage forms.
Research Interest
bioavailability studies clinical research parenterals

The Pharmacokinetics of Fluticasone Furoate and Vilanterol Following Single Inhaled Administration in Combination and Intravenous Administration of Individual Components in Healthy Subjects

Ann Allen, Ludovic Apoux , Jo Bal , Joseph Bianco , Alison Moore , Ramiya Ravindranath , Lee Tombs and Rodger D Kempsford

Research Article: J Bioequiv Availab 2013, 5: 165-173

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version